{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:08:06Z","timestamp":1794366486963,"version":"4.9.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tampere University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04892-y","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:57:11Z","timestamp":1777053431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Valeriia","family":"Dotsenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana Hien","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Raji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Moulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalmari","family":"Kettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Karoliina","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuulia","family":"Hy\u00f6tyl\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Tewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Mohrbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Suomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lahesmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Ore\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Elo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Raitoharju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"M\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijo","family":"Viiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CEC-3 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"4","key":"4892_CR1","doi-asserted-by":"publisher","first-page":"G996","DOI":"10.1152\/ajpgi.00136.2002","volume":"283","author":"F Hausch","year":"2002","unstructured":"Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 2002;283(4):G996\u20131003.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"4892_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association. 2018;16(6):823\u2013e8362.","journal-title":"Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association"},{"issue":"1","key":"4892_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0054-z","volume":"5","author":"K Lindfors","year":"2019","unstructured":"Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5(1):3.","journal-title":"Nat Rev Dis Primers"},{"issue":"4 Suppl 1","key":"4892_CR4","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1053\/j.gastro.2005.02.016","volume":"128","author":"PHR Green","year":"2005","unstructured":"Green PHR. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128(4 Suppl 1):S74\u201378.","journal-title":"Gastroenterology"},{"key":"4892_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.yapd.2008.07.001","volume":"55","author":"JM Barker","year":"2008","unstructured":"Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr. 2008;55:349\u201365.","journal-title":"Adv Pediatr"},{"issue":"5","key":"4892_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1053\/j.gastro.2021.08.016","volume":"161","author":"EF Verdu","year":"2021","unstructured":"Verdu EF, Schuppan D. Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment. Gastroenterology. 2021;161(5):1395\u2013e14114.","journal-title":"Gastroenterology"},{"issue":"1","key":"4892_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.gastro.2024.03.042","volume":"167","author":"V Abadie","year":"2024","unstructured":"Abadie V, Han AS, Jabri B, Sollid LM. New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease. Gastroenterology. 2024;167(1):4\u201322.","journal-title":"Gastroenterology"},{"issue":"24","key":"4892_CR8","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.3390\/ijms232415564","volume":"23","author":"M Giuffr\u00e8","year":"2022","unstructured":"Giuffr\u00e8 M, Gazzin S, Zoratti C, Llido JP, Lanza G, Tiribelli C, et al. Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation. Int J Mol Sci. 2022;23(24):15564.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4892_CR9","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/nu13061846","volume":"13","author":"M Hadjivassiliou","year":"2021","unstructured":"Hadjivassiliou M, Croall ID, Gr\u00fcnewald RA, Trott N, Sanders DS, Hoggard N. Neurological Evaluation of Patients with Newly Diagnosed Coeliac Disease Presenting to Gastroenterologists: A 7-Year Follow-Up Study. Nutrients. 2021;13(6):1846.","journal-title":"Nutrients"},{"issue":"5","key":"4892_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12664-021-01215-2","volume":"40","author":"N Sharma","year":"2021","unstructured":"Sharma N, Singh K, Senapati S. Celiac disease poses significant risk in developing depression, anxiety, headache, epilepsy, panic disorder, dysthymia: A meta-analysis. Indian J Gastroenterol. 2021;40(5):453\u201362.","journal-title":"Indian J Gastroenterol"},{"key":"4892_CR11","doi-asserted-by":"publisher","first-page":"116913","DOI":"10.1016\/j.bone.2023.116913","volume":"177","author":"S Hansen","year":"2023","unstructured":"Hansen S, Schwarz P, Rumessen J, Linneberg A, K\u00e5rhus LL. Osteoporosis and bone fractures in patients with celiac disease: A nationwide cohort study. Bone. 2023;177:116913.","journal-title":"Bone"},{"issue":"1","key":"4892_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/jc.2014-1858","volume":"100","author":"K Heikkil\u00e4","year":"2015","unstructured":"Heikkil\u00e4 K, Pearce J, M\u00e4ki M, Kaukinen K. Celiac disease and bone fractures: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(1):25\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4892_CR13","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/ndt\/gfl117","volume":"21","author":"JF Ludvigsson","year":"2006","unstructured":"Ludvigsson JF, Montgomery SM, Ol\u00e9n O, Ekbom A, Ludvigsson J, Fored M. Coeliac disease and risk of renal disease-a general population cohort study. Nephrol Dial Transpl. 2006;21(7):1809\u201315.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4892_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/joim.13532","volume":"292","author":"R Nurmi","year":"2022","unstructured":"Nurmi R, Pasternack C, Salmi T, Hervonen K, Koskinen I, J\u00e4rvelin J, et al. The risk of renal comorbidities in celiac disease patients depends on the phenotype of celiac disease. J Intern Med. 2022;292(5):779\u201387.","journal-title":"J Intern Med"},{"issue":"12","key":"4892_CR15","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.dld.2016.08.115","volume":"48","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Thamcharoen N, Pachariyanon P, Nakkala K, et al. Celiac disease and the risk of kidney diseases: A systematic review and meta-analysis. Dig Liver Dis. 2016;48(12):1418\u201324.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"4892_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1210\/er.2001-0035","volume":"23","author":"P Collin","year":"2002","unstructured":"Collin P, Kaukinen K, V\u00e4lim\u00e4ki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23(4):464\u201383.","journal-title":"Endocr Rev"},{"issue":"1","key":"4892_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/00365528909092243","volume":"24","author":"P Collin","year":"1989","unstructured":"Collin P, Salmi J, H\u00e4llstr\u00f6m O, Oksa H, Oksala H, M\u00e4ki M, et al. High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol. 1989;24(1):81\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"4892_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5009\/gnl.2009.3.4.237","volume":"3","author":"HJ Freeman","year":"2009","unstructured":"Freeman HJ. Adult celiac disease and its malignant complications. Gut Liver. 2009;3(4):237\u201346.","journal-title":"Gut Liver"},{"issue":"2","key":"4892_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/ijerph20021565","volume":"20","author":"I Gromny","year":"2023","unstructured":"Gromny I, Neubauer K. Pancreatic Cancer in Celiac Disease Patients-A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2023;20(2):1565.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4892_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13256-022-03682-3","volume":"16","author":"B Packova","year":"2022","unstructured":"Packova B, Kohout P, Dastych M, Prokesova J, Grolich T, Kroupa R. Malignant complications of celiac disease: a case series and review of the literature. J Med Case Rep. 2022;16(1):460.","journal-title":"J Med Case Rep"},{"issue":"1","key":"4892_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","volume":"17","author":"G De Caio","year":"2019","unstructured":"Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current review. BMC Med. 2019;17(1):142.","journal-title":"BMC Med"},{"issue":"1","key":"4892_CR22","first-page":"13","volume":"11","author":"V Dotsenko","year":"2021","unstructured":"Dotsenko V, Oittinen M, Taavela J, Popp A, Per\u00e4aho M, Staff S, et al. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge. CMGH. 2021;11(1):13\u201332.","journal-title":"CMGH"},{"issue":"5","key":"4892_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","volume":"158","author":"JA Silvester","year":"2020","unstructured":"Silvester JA, Comino I, Kelly CP, Sousa C, Duerksen DR, DOGGIE BAG Study Group. Most Patients With Celiac Disease on Gluten-Free Diets Consume Measurable Amounts of Gluten. Gastroenterology. 2020;158(5):1497\u2013e14991.","journal-title":"Gastroenterology"},{"issue":"1","key":"4892_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ygh2.380","volume":"2","author":"AJM Daveson","year":"2020","unstructured":"Daveson AJM, Popp A, Taavela J, Goldstein KE, Isola J, Truitt KE, et al. Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten-free diet. GastroHep. 2020;2(1):22\u201330.","journal-title":"GastroHep"},{"key":"4892_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","volume":"17","author":"G De Caio","year":"2019","unstructured":"Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current review. BMC Med. 2019;17:142.","journal-title":"BMC Med"},{"issue":"3","key":"4892_CR26","first-page":"139","volume":"7","author":"G Samasca","year":"2014","unstructured":"Samasca G, Sur G, Lupan I, Deleanu D. Gluten-free diet and quality of life in celiac disease. Gastroenterol Hepatol Bed Bench. 2014;7(3):139\u201343.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"4892_CR27","doi-asserted-by":"crossref","unstructured":"Besser HA, Khosla C. Celiac disease: mechanisms and emerging therapeutics. Trends in Pharmacological Sciences. 2023.","DOI":"10.1016\/j.tips.2023.09.006"},{"issue":"3","key":"4892_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","volume":"18","author":"L Kivel\u00e4","year":"2021","unstructured":"Kivel\u00e4 L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol. 2021;18(3):181\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"4892_CR29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/cells11101667","volume":"11","author":"C B\u00fcchold","year":"2022","unstructured":"B\u00fcchold C, Hils M, Gerlach U, Weber J, Pelzer C, Heil A, et al. Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease. Cells. 2022;11(10):1667.","journal-title":"Cells"},{"issue":"1","key":"4892_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2032441","volume":"385","author":"D Schuppan","year":"2021","unstructured":"Schuppan D, M\u00e4ki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, et al. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease. N Engl J Med. 2021;385(1):35\u201345.","journal-title":"N Engl J Med"},{"issue":"7","key":"4892_CR31","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41590-024-01867-0","volume":"25","author":"V Dotsenko","year":"2024","unstructured":"Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, et al. Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease. Nat Immunol. 2024;25(7):1218\u201330.","journal-title":"Nat Immunol"},{"issue":"2","key":"4892_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/pr100896s","volume":"10","author":"P la Bernini","year":"2011","unstructured":"Bernini P, Bertini I, Calabr\u00f2 A, la Marca G, Lami G, Luchinat C, et al. Are Patients with Potential Celiac Disease Really Potential? The Answer of Metabonomics. J Proteome Res. 2011;10(2):714\u201321.","journal-title":"J Proteome Res"},{"issue":"1","key":"4892_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50735-7","volume":"9","author":"R De Auricchio","year":"2019","unstructured":"Auricchio R, Galatola M, Cielo D, Amoresano A, Caterino M, De Vita E, et al. A Phospholipid Profile at 4 Months Predicts the Onset of Celiac Disease in at-Risk Infants. Sci Rep. 2019;9(1):1.","journal-title":"Sci Rep"},{"issue":"5","key":"4892_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000044","volume":"10","author":"P Sen","year":"2019","unstructured":"Sen P, Carlsson C, Virtanen SM, Simell S, Hy\u00f6ty H, Ilonen J, et al. Persistent Alterations in Plasma Lipid Profiles Before Introduction of Gluten in the Diet Associated With Progression to Celiac Disease. Clin Transl Gastroenterol. 2019;10(5):1\u201310.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"4892_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/pr800548z","volume":"8","author":"I De Bertini","year":"2009","unstructured":"Bertini I, Calabr\u00f2 A, De Carli V, Luchinat C, Nepi S, Porfirio B, et al. The Metabonomic Signature of Celiac Disease. J Proteome Res. 2009;8(1):170\u20137.","journal-title":"J Proteome Res"},{"issue":"9","key":"4892_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.amjmed.2005.12.025","volume":"119","author":"P Brar","year":"2006","unstructured":"Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, et al. Change in Lipid Profile in Celiac Disease: Beneficial Effect of Gluten-Free Diet. Am J Med. 2006;119(9):786\u201390.","journal-title":"Am J Med"},{"issue":"3","key":"4892_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/j.gastro.2024.03.006","volume":"167","author":"A Johansen","year":"2024","unstructured":"Johansen A, Sandve GKF, Ibsen JH, Lundin KEA, Sollid LM, Stamnaes J. Biopsy Proteome Scoring to Determine Mucosal Remodeling in Celiac Disease. Gastroenterology. 2024;167(3):493\u2013e50410.","journal-title":"Gastroenterology"},{"issue":"5","key":"4892_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cgh.2024.08.005","volume":"23","author":"A Johansen","year":"2025","unstructured":"Johansen A, Sandve GKF, Maxwell JR, Smithson G, Sollid LM, Stamnaes J. Biopsy Proteome Score Performs Well as an Effect Measure in a Gluten Challenge Trial of Celiac Disease. Clin Gastroenterol Hepatol. 2025;23(5):758\u2013e7658.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"4892_CR39","doi-asserted-by":"publisher","first-page":"29872","DOI":"10.1038\/s41598-024-80391-5","volume":"14","author":"N Li","year":"2024","unstructured":"Li N, Maimaitireyimu A, Shi T, Feng Y, Liu W, Xue S, et al. Proteomic analysis of plasma and duodenal tissue in celiac disease patients reveals potential noninvasive diagnostic biomarkers. Sci Rep. 2024;14(1):29872.","journal-title":"Sci Rep"},{"issue":"2","key":"4892_CR40","doi-asserted-by":"publisher","first-page":"e14980","DOI":"10.1111\/nmo.14980","volume":"37","author":"S Mahurkar-Joshi","year":"2025","unstructured":"Mahurkar-Joshi S, Thompson M, Villarruel E, Lewis JD, Lin LD, Farid M, et al. Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease. Neurogastroenterology Motil. 2025;37(2):e14980.","journal-title":"Neurogastroenterology Motil"},{"issue":"8","key":"4892_CR41","doi-asserted-by":"publisher","first-page":"eaaw7756","DOI":"10.1126\/sciadv.aaw7756","volume":"5","author":"G Goel","year":"2019","unstructured":"Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019;5(8):eaaw7756.","journal-title":"Sci Adv"},{"issue":"1","key":"4892_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cei.13369","volume":"199","author":"G Goel","year":"2020","unstructured":"Goel G, Daveson AJM, Hooi CE, Tye-Din JA, Wang S, Szymczak E, et al. Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease. Clin Exp Immunol. 2020;199(1):68\u201378.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"4892_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497\u2013509.","journal-title":"J Biol Chem"},{"issue":"11","key":"4892_CR44","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s00125-023-05974-9","volume":"66","author":"R Moulder","year":"2023","unstructured":"Moulder R, V\u00e4likangas T, Hirvonen MK, Suomi T, Brorsson CA, Lietz\u00e9n N, et al. Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory. Diabetologia. 2023;66(11):1983\u201396.","journal-title":"Diabetologia"},{"key":"4892_CR45","doi-asserted-by":"crossref","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis [Internet]. bioRxiv; 2021 [cited 2025 Oct 8]. p. 060012. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/060012v3 doi:10.1101\/060012","DOI":"10.1101\/060012"},{"issue":"1","key":"4892_CR46","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1038\/s41467-023-39869-5","volume":"14","author":"F Yu","year":"2023","unstructured":"Yu F, Teo GC, Kong AT, Fr\u00f6hlich K, Li GX, Demichev V, et al. Analysis of DIA proteomics data using MSFragger-DIA and FragPipe computational platform. Nat Commun. 2023;14(1):4154.","journal-title":"Nat Commun"},{"issue":"9","key":"4892_CR47","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1021\/acs.jproteome.2c00145","volume":"21","author":"AM Frankenfield","year":"2022","unstructured":"Frankenfield AM, Ni J, Ahmed M, Hao L. Protein Contaminants Matter: Building Universal Protein Contaminant Libraries for DDA and DIA Proteomics. J Proteome Res. 2022;21(9):2104\u201313.","journal-title":"J Proteome Res"},{"key":"4892_CR48","unstructured":"ROTS: An R package for reproducibility-optimized statistical testing | PLOS Computational Biology [Internet]. [cited 2025 Oct 8]. Available from: https:\/\/journals.plos.org\/ploscompbiol\/article?id=10.1371\/journal.pcbi.1005562"},{"issue":"1","key":"4892_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Royal Stat Soc J Ser B: Methodological. 1995;57(1):289\u2013300.","journal-title":"Royal Stat Soc J Ser B: Methodological"},{"issue":"11","key":"4892_CR50","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart F, Gautier B, Singh A, Cao KAL, mixOmics. An R package for \u2018omics feature selection and multiple data integration. PLoS Comput Biol. 2017;13(11):e1005752.","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"4892_CR51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","volume":"2","author":"PE Geyer","year":"2016","unstructured":"Geyer PE, Kulak NA, Pichler G, Holdt LM, Teupser D, Mann M. Plasma Proteome Profiling to Assess Human Health and Disease. Cell Syst. 2016;2(3):185\u201395.","journal-title":"Cell Syst"},{"issue":"11","key":"4892_CR52","doi-asserted-by":"publisher","first-page":"e10427","DOI":"10.15252\/emmm.201910427","volume":"11","author":"PE Geyer","year":"2019","unstructured":"Geyer PE, Voytik E, Treit PV, Doll S, Kleinhempel A, Niu L, et al. Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies. EMBO Mol Med. 2019;11(11):e10427.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4892_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/hep.510250127","volume":"25","author":"S Kr\u00e4henb\u00fchl","year":"1997","unstructured":"Kr\u00e4henb\u00fchl S, Reichen J. Carnitine metabolism in patients with chronic liver disease. Hepatology. 1997;25(1):148\u201353.","journal-title":"Hepatology"},{"issue":"7","key":"4892_CR54","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/nu12071915","volume":"12","author":"T Hanai","year":"2020","unstructured":"Hanai T, Shiraki M, Imai K, Suetugu A, Takai K, Shimizu M. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis. Nutrients. 2020;12(7):1915.","journal-title":"Nutrients"},{"issue":"4","key":"4892_CR55","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/j.1523-1755.2004.00916.x","volume":"66","author":"AM Evans","year":"2004","unstructured":"Evans AM, Faull RJ, Nation RL, Prasad S, Elias T, Reuter SE, et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int. 2004;66(4):1527\u201334.","journal-title":"Kidney Int"},{"issue":"2","key":"4892_CR56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1017\/S0007114507705020","volume":"98","author":"J Bene","year":"2007","unstructured":"Bene J, Koml\u00f3si K, Magyari L, Tali\u00e1n G, Horv\u00e1th K, Gasztonyi B, et al. Plasma carnitine ester profiles in Crohn\u2019s disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207 C genotypes. Br J Nutr. 2007;98(2):345\u201350.","journal-title":"Br J Nutr"},{"issue":"42","key":"4892_CR57","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.3748\/wjg.v11.i42.6671","volume":"11","author":"J Bene","year":"2005","unstructured":"Bene J, Koml\u00f3si K, Gasztonyi B, Juh\u00e1sz M, Tulassay Z, Melegh B. Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J Gastroenterol. 2005;11(42):6671\u20135.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4892_CR58","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/nu13072271","volume":"13","author":"R Mart\u00edn-Masot","year":"2021","unstructured":"Mart\u00edn-Masot R, Galo-Licona JD, Mota-Martorell N, Sol J, Jov\u00e9 M, Maldonado J, et al. Up-Regulation of Specific Bioactive Lipids in Celiac Disease. Nutrients. 2021;13(7):2271.","journal-title":"Nutrients"},{"issue":"2","key":"4892_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/MPG.0000000000000561","volume":"60","author":"A T\u00e1rnok","year":"2015","unstructured":"T\u00e1rnok A, Marosv\u00f6lgyi T, Szab\u00f3 \u00c9, Gy\u00f6rei E, Decsi T. Low n-3 long-chain polyunsaturated fatty acids in newly diagnosed celiac disease in children with preexisting type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 2015;60(2):255.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4892_CR60","doi-asserted-by":"crossref","unstructured":"Beimers WF, Overmyer KA, Sinitcyn P, Lancaster NM, Quarmby ST, Coon JJ. A Technical Evaluation of Plasma Proteomics Technologies [Internet]. bioRxiv; 2025 [cited 2026 Mar 4]. p. 2025.01.08.632035. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.01.08.632035v1 doi:10.1101\/2025.01.08.632035","DOI":"10.1101\/2025.01.08.632035"},{"issue":"2","key":"4892_CR61","doi-asserted-by":"publisher","first-page":"126","DOI":"10.23736\/S0026-4806.17.05403-9","volume":"109","author":"B Boonpheng","year":"2018","unstructured":"Boonpheng B, Cheungpasitporn W, Wijarnpreecha K. Renal disease in patients with celiac disease. Minerva Med. 2018;109(2):126\u201340. .","journal-title":"Minerva Med"},{"issue":"12","key":"4892_CR62","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.dld.2016.08.115","volume":"48","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Thamcharoen N, Pachariyanon P, Nakkala K, et al. Celiac disease and the risk of kidney diseases: A systematic review and meta-analysis. Dig Liver Dis. 2016;48(12):1418\u201324.","journal-title":"Dig Liver Dis"},{"key":"4892_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.abb.2015.07.018","volume":"589","author":"M Breit","year":"2016","unstructured":"Breit M, Weinberger KM. Metabolic biomarkers for chronic kidney disease. Arch Biochem Biophys. 2016;589:62\u201380.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"4892_CR64","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2215\/CJN.07650717","volume":"13","author":"F Wang","year":"2018","unstructured":"Wang F, Sun L, Sun Q, Liang L, Gao X, Li R, et al. Associations of plasma amino acid and acylcarnitine profiles with incident reduced glomerular filtration rate. Clin J Am Soc Nephrol. 2018;13(4):560\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1\u20134","key":"4892_CR65","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.ddmec.2009.02.001","volume":"6","author":"S Sharma","year":"2009","unstructured":"Sharma S, Black SM. Carnitine homeostasis, mitochondrial function, and cardiovascular disease. Drug Discov Today Dis Mech. 2009;6(1\u20134):e31\u20139.","journal-title":"Drug Discov Today Dis Mech"},{"issue":"5","key":"4892_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol. 2017;13(5):5.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"4892_CR67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.01.014","volume":"60","author":"ON Goek","year":"2012","unstructured":"Goek ON, D\u00f6ring A, Gieger C, Heier M, Koenig W, Prehn C, et al. Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis. 2012;60(2):197\u2013206.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4892_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12986-018-0328-1","volume":"16","author":"FY Xia","year":"2019","unstructured":"Xia FY, Zhu L, Xu C, Wu QQ, Chen WJ, Zeng R, et al. Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy. Nutr Metabolism. 2019;16(1):2.","journal-title":"Nutr Metabolism"},{"issue":"10","key":"4892_CR69","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422\u201335.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"4892_CR70","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2174\/1566524019666191113120828","volume":"20","author":"J Bene","year":"2020","unstructured":"Bene J, Szabo A, Koml\u00f3si K, Melegh B. Mass spectrometric analysis of L-carnitine and its esters: potential biomarkers of disturbances in carnitine homeostasis. CMM. 2020;20(5):336\u201354.","journal-title":"CMM"},{"issue":"7","key":"4892_CR71","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gut.34.7.933","volume":"34","author":"A Lerner","year":"1993","unstructured":"Lerner A, Gruener N, Iancu TC. Serum carnitine concentrations in coeliac disease. Gut. 1993;34(7):933\u20135.","journal-title":"Gut"},{"issue":"42","key":"4892_CR72","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.3748\/wjg.v11.i42.6671","volume":"11","author":"J Bene","year":"2005","unstructured":"Bene J, Koml\u00f3si K, Gasztonyi B, Juh\u00e1sz M, Tulassay Z, Melegh B. Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J Gastroenterol. 2005;11(42):6671\u20135.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4892_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-022-01429-2","volume":"11","author":"K Girdhar","year":"2023","unstructured":"Girdhar K, Dogru YD, Huang Q, Yang Y, Tolstikov V, Raisingani A, et al. Dynamics of the gut microbiome, IgA response, and plasma metabolome in the development of pediatric celiac disease. Microbiome. 2023;11(1):9.","journal-title":"Microbiome"},{"issue":"7","key":"4892_CR74","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3109\/00365527709181733","volume":"12","author":"P Teisberg","year":"1977","unstructured":"Teisberg P, Fausa O, Baklien K, Akesson I. Complement system studies in adult coeliac disease. Scand J Gastroenterol. 1977;12(7):873\u20136.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"4892_CR75","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/gut.30.11.1568","volume":"30","author":"RB Gallagher","year":"1989","unstructured":"Gallagher RB, Kelly CP, Neville S, Sheils O, Weir DG, Feighery CF. Complement activation within the coeliac small intestine is localised to Brunner\u2019s glands. Gut. 1989;30(11):1568\u201373.","journal-title":"Gut"},{"key":"4892_CR76","doi-asserted-by":"publisher","first-page":"138797","DOI":"10.1155\/2012\/138797","volume":"2012","author":"DC Kilpatrick","year":"2012","unstructured":"Kilpatrick DC, Chalmers JD. Human L-ficolin (ficolin-2) and its clinical significance. J Biomed Biotechnol. 2012;2012:138797.","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"4892_CR77","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/ijerph18031122","volume":"18","author":"P Monti","year":"2021","unstructured":"Monti P, Iodice S, Tarantini L, Sacchi F, Ferrari L, Ruscica M, et al. Effects of PM Exposure on the Methylation of Clock Genes in A Population of Subjects with Overweight or Obesity. Int J Environ Res Public Health. 2021;18(3):1122.","journal-title":"Int J Environ Res Public Health"},{"key":"4892_CR78","doi-asserted-by":"crossref","unstructured":"Radhakrishna U, Ratnamala U, Jhala DD, Uppala LV, Vedangi A, Saiyed N et al. DNA methylation patterns of circadian and ultradian genes are altered in the peripheral blood of patients with hidradenitis suppurativa. Front Immunol. 2024;15.","DOI":"10.3389\/fimmu.2024.1475424"},{"issue":"14","key":"4892_CR79","doi-asserted-by":"publisher","first-page":"e170998","DOI":"10.1172\/JCI170998","volume":"134","author":"LA Schrader","year":"2024","unstructured":"Schrader LA, Ronnekleiv-Kelly SM, Hogenesch JB, Bradfield CA, Malecki KM. Circadian disruption, clock genes, and metabolic health. J Clin Invest. 2024;134(14):e170998.","journal-title":"J Clin Invest"},{"issue":"D1","key":"4892_CR80","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u201352.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04892-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04892-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04892-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:41:34Z","timestamp":1781649694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04892-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4892"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04892-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TUKIJA dnro 223\/06.00.01\/2017, EudraCT 2017-002241-30 for Dr. Falk Pharma funded clinical trial. The study was conducted with de-identified data of the participants who had consented to the use of their anonymized data in research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Valeriia Dotsenko, none to declare.\u00a0Hana Hien Le, none to declare. Sonja Rajic, none to declare. Robert Moulder, none to declare. Jalmari Kettunen, none to declare. M. Karoliina Hirvonen, none to declare. Alex M Dickens, none to declare. Tuulia Hy\u00f6tyl\u00e4inen, none to declare. Bernhard Tewes, employee of Dr. Falk Pharma GmbH. Timo Zimmermann, employee of Dr. Falk Pharma GmbH. Ralf Mohrbacher, employee of Dr. Falk Pharma GmbH. Tomi Suomi, none to declare. Terho Lehtim\u00e4ki, none to declare. Riitta Lahesmaa, none to declare. Matej Oresic, none to declare. Laura Elo, none to declare. Emma Raitoharju, none to declare. Detlef Schuppan, consultant for Falk Pharma, Chugai, Immunic, Sanofi and Tillots. Markku M\u00e4ki,\u00a0is the founder, owner, and chair of board at Maki HealthTech Ltd (MHT). MHT has received during the last three years Management\/Advisory Affiliation fees from Dr. Falk Pharma, Interlude Biopharma, Entero Therapeutics, Calypso Biotech, ImmunogenX, and Immunic; holds patent licensed to Labsystems Diagnostics from where MHT has received royalties via Tampere University Hospital.\u00a0Keijo Viiri, none to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}